Tezepelumab Reduces Oral Corticosteroid Dependence in Severe Asthma, Case Report Shows Functional Recovery
A placebo-controlled trial shows tezepelumab significantly reduces oral corticosteroid dependence in severe asthma, with patients achieving nearly three times the odds of reduction versus placebo. A separate case report documents dramatic functional recovery in an elderly patient who switched from mepolizumab to tezepelumab after inadequate response.